Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Trang, H; Brunet, JF; Rohrer, H; Gallego, J; Amiel, J; Bachetti, T; Fischbeck, KH; Similowski, T; Straus, C; Ceccherini, I; Weese-Mayer, DE; Frerick, M; Bieganowska, K; Middleton, L; Morandi, F; Ottonello, G; European Central Hypoventilation Syndrome Consortium.
Proceedings of the fourth international conference on central hypoventilation.
Orphanet J Rare Dis. 2014; 9: 194-194.
Doi: 10.1186/s13023-014-0194-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Study Group Members Med Uni Graz:
- Pfleger Andreas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung's disease (ORPHA99803) and neural crest tumours in 20% and 5% of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways.The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13-15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.
- Find related publications in this database (using NLM MeSH Indexing)
- Congresses as Topic - trends
- Humans -
- Hypoventilation - congenital
- Hypoventilation - diagnosis
- Hypoventilation - epidemiology
- Hypoventilation - therapy
- Interactive Ventilatory Support - methods
- Interactive Ventilatory Support - trends
- Internationality -
- Internationality -
- Sleep Apnea, Central - diagnosis
- Sleep Apnea, Central - epidemiology
- Sleep Apnea, Central - therapy
- Find related publications in this database (Keywords)
- Central hypoventilation
- Autonomic nervous system
- Congenital central hypoventilation syndrome
- PHOX2B gene
- Hirschsprung's disease
- Alanine expansion
- Central control of breathing
- Home mechanical ventilation
- Phrenic nerve stimulation
- Diaphragmatic stimulation